Last10K.com

Tonix Pharmaceuticals Holding Corp. (TNXP) SEC Filing 8-K Material Event for the period ending Thursday, October 18, 2018

Tonix Pharmaceuticals Holding Corp.

HISTORY TOOLS
CIK: 1430306 Ticker: TNXP

View differences made from one to another to evaluate Tonix Pharmaceuticals Holding Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Tonix Pharmaceuticals Holding Corp..

Continue

Assess how Tonix Pharmaceuticals Holding Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Tonix Pharmaceuticals Holding Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Tonix Pharmaceuticals Holding Corp. provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Material Contract
Exhibit 10.2: Material Contract
Ticker: TNXP
CIK: 1430306
Form Type: 8-K Corporate News
Accession Number: 0001615774-18-011277
Submitted to the SEC: Wed Oct 24 2018 4:05:23 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Thursday, October 18, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Listing Status
  3. New Agreement
  4. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/tnxp/0001615774-18-011277.htm